Clinical trial Recruiting at 1 site Observational Ages 8 to 15

Evaluation of a new implant for lower limb deformity in children

Official title: Clinical-MRI Evaluation in Patients Undergoing Subtalar Arthrorisis With Resorbable PLLA Endothesis Implant: Prospective Observational Study at 5 Years of Minimum Follow-up

Run by Istituto Ortopedico Rizzoli · NCT06525532 · Data updated 2026-11-12

This study looks at how well a new implant works for correcting lower limb deformities in children aged 8 to 15 who have had the procedure, by reviewing their medical records over five years.

More Deformity of Limb trials

Quick facts

Study typeObservational
Ages8 Years to 15 Years
SexAll
Enrollment35 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedJune 12, 2024
Main results expectedNovember 2026
Study endsDecember 2026
Registry record updatedDecember 29, 2025
Trial IDNCT06525532 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 8 to 15 years who have undergone subtalar arthrorrhesis with the specified implant.

Probably not a fit

Patients with significant prior lower limb trauma, chronic infections, or other specified exclusions will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will analyze cases of subtalar arthrorrhesis using a reabsorbable endorthotic implant made of PLLA, retrieved from the archives of the IRCCS Rizzoli Orthopedic Institute. An electronic database will be created to review the medical records of these patients, focusing on those aged 8 to 15 years who have undergone the procedure. The study will assess the outcomes over a minimum follow-up period of five years without a control group or comparison to other therapeutic procedures.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness of a new implant for treating lower limb deformities in children.

How similar studies have gone: While this approach is specific, similar studies evaluating pediatric orthopedic implants have shown promising results in the past.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 8 and 15 years at the time of surgery
* Arthrorrhosis of the subtalar with reabsorbable endorthotic implant in PLLA
* Minimum follow-up of 5 years

Exclusion Criteria:

* Revisions/explantation of the endorthesis device
* Patients with active acute or chronic infections
* Patients with chronic inflammatory joint diseases
* Patients with previous significant trauma of the lower limbs following surgery
* Patients with pre-existing anomalies of ambulatory kinematics (amputations, neuro-muscular diseases, poliomyelitis, hip dysplasias)
* Patients with cognitive deficits
* \- Patients with concomitant neurological pathologies
* Patients suffering from tumor pathology
* Patients with cardiac pacemakers or other prostheses equipped with electronic circuits
* Patients with intracranial metal implants, metal heart valves, vascular clips, ferromagnetic endovascular filters/stents/coils, Swan-Ganz catheters or in any case positioned close to vital anatomical structures
* Patients with orthopedic metal prostheses
* Patients with cochlear implants or fixed hearing aids, lens prostheses with ferromagnetic intra-ocular points, IUD (coil) or splinters made of ferromagnetic material
* Pregnant patients
* Patients with insulin pumps and non-removable contact lenses

Where it's running

  • Istituto Ortopedico Rizzoli
    Bologna, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.